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Abstract
COPII vesicles bud from an ER domain known as the transitional ER (tER). Assembly of the COPII coat is initiated by the
transmembrane guanine nucleotide exchange factor Sec12. In the budding yeast Pichia pastoris, Sec12 is concentrated at
tER sites. Previously, we found that the tER localization of P. pastoris Sec12 requires a saturable binding partner. We now
show that this binding partner is Sec16, a peripheral membrane protein that functions in ER export and tER organization.
One line of evidence is that overexpression of Sec12 delocalizes Sec12 to the general ER, but simultaneous overexpression
of Sec16 retains overexpressed Sec12 at tER sites. Additionally, when P. pastoris Sec12 is expressed in S. cerevisiae, the
exogenous Sec12 localizes to the general ER, but when P. pastoris Sec16 is expressed in the same cells, the exogenous Sec12
is recruited to tER sites. In both of these experimental systems, the ability of Sec16 to recruit Sec12 to tER sites is abolished
by deleting a C-terminal fragment of Sec16. Biochemical experiments confirm that this C-terminal fragment of Sec16 binds
to the cytosolic domain of Sec12. Similarly, we demonstrate that human Sec12 is concentrated at tER sites, likely due to
association with a C-terminal fragment of Sec16A. These results suggest that a Sec12–Sec16 interaction has a conserved role
in ER export.
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Introduction
In the secretory pathway, newly synthesized proteins are
exported from the ER in COPII coated transport vesicles
[1,2,3]. COPII vesicles bud from ribosome-free ER domains
known as transitional ER (tER) sites or ER exit sites [4,5,6]. The
mechanism that generates tER sites is unknown, but our working
model is that tER sites form by a self-organization process that
depends on the specific properties of components involved in
COPII assembly [7,8]. Therefore, an analysis of tER site
formation must build on knowledge of how COPII coat proteins
interact with each other and with partner proteins.
The first step in COPII coat assembly is the exchange of GDP
for GTP on the small GTPase Sar1. This reaction is catalyzed by
the guanine nucleotide exchange factor Sec12, which spans the
ER membrane with its catalytic domain facing the cytosol [9].
Sar1-GTP associates with the ER membrane and recruits the
Sec23/24 heterodimer. Sec23 acts as a GTPase activating protein
for Sar1, while Sec24 functions to capture cargo into the nascent
vesicle [2]. Sec23/24 binds the Sec13/31 heterodimer, which
polymerizes to form the outer shell of the coat [10]. In all
eukaryotes studied to date, Sec23/24 and Sec13/31 localize to
punctate ER regions that operationally define tER sites [5].
By contrast, the localization of Sec12 is variable. In the budding
yeast Pichia pastoris, Sec12 is concentrated at tER sites [11,12], but
in Saccharomyces cerevisiae, Sec12 is found throughout the ER
[11,13]. This variability suggests that Sec12 localization does not
establish tER sites, and indeed, mutations that delocalize P. pastoris
Sec12 (PpSec12) to the general ER do not prevent tER site
formation [12]. Instead, PpSec12 is recruited to tER sites by a
partner protein that interacts with the PpSec12 cytosolic domain
[12]. Overexpression of PpSec12 results in localization to the
general ER, indicating that binding by the partner protein is
saturable [12]. Identification of the partner protein should help to
clarify the functional significance of this novel Sec12 interaction.
A candidate for the PpSec12 partner protein is Sec16, a large
peripheral ER membrane protein that functions in ER export and
interacts with multiple COPII pathway components [14,15,16]. In
previous work, we isolated a thermosensitive P. pastoris mutant with
fragmented tER sites, and identified the cause of the defect as a
missense mutation in SEC16 [8]. Sec16 colocalizes with COPII
coat proteins at tER sites in both P. pastoris and S. cerevisiae [8].
Mammalian and Drosophila cells also contain Sec16 homologs that
localize to tER sites and play a key role in tER organization
[17,18,19,20,21]. In the P. pastoris sec16 strain at the nonpermissive
temperature, most of the mutant Sec16 protein is displaced from
tER sites, and most of the PpSec12 is delocalized to the general
ER [8], consistent with the idea that P. pastoris Sec16 (PpSec16)
recruits PpSec12 to tER sites.
Here, we demonstrate that a C-terminal fragment of PpSec16
binds to PpSec12, and that this interaction recruits PpSec12 to
tER sites. Moreover, mammalian Sec12 is concentrated at tER
sites, and the cytosolic domain of mammalian Sec12 can bind to a
C-terminal fragment of Sec16A, which is the mammalian ortholog
of yeast Sec16. Thus, the Sec12–Sec16 interaction may have a
conserved role in generating COPII vesicles and tER sites.
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Overexpression of PpSec16 in P. pastoris restores tER
localization to overexpressed PpSec12
When Glu-Glu epitope-tagged PpSec12 (PpSec12-GG) was
expressed at normal levels in P. pastoris, this protein localized to
tER sites, but when untagged PpSec12 was overexpressed in the
same cells, most of the PpSec12-GG molecules were found in the
general ER [12]. This general ER pattern included partial or
complete fluorescent rings representing the nuclear envelope
(Fig. 1, top row). We infer that the PpSec12-GG molecules marked
the distribution of the combined pool of tagged and untagged
PpSec12 molecules, and that this combined pool had saturated the
tER-localized partner protein.
Cells expressing PpSec12-GG and overexpressing PpSec12
were engineered to express GFP-tagged PpSec16 (PpSec16-GFP)
at either normal or elevated levels. When PpSec16-GFP was
expressed at normal levels, it localized to punctate tER sites that
contained only a small fraction of the PpSec12-GG (Fig. 1, top
row). However, when PpSec16-GFP was overexpressed, it was
found in abnormally large punctate structures that also contained
most of the PpSec12-GG (Fig. 1, bottom row). The large punctate
structures generated by simultaneous overexpression of PpSec12
and PpSec16 were exaggerated tER sites because they also
contained the COPII coat protein Sec13 (Fig. S1). These results
are consistent with the idea that PpSec12 binds PpSec16, and that
overexpressed PpSec16 recruits overexpressed PpSec12 to tER
sites.
PpSec16 can recruit PpSec12 to tER sites in S. cerevisiae
As a further test of whether PpSec16 can recruit PpSec12 to
tER sites, we expressed both proteins in S. cerevisiae, which has
numerous small tER sites [11,22,23]. When either PpSec12-GG or
Glu-Glu epitope-tagged S. cerevisiae Sec12 (ScSec12-GG) was
expressed alone in S. cerevisiae, the tagged Sec12 was found in the
general ER (Fig. 2A) as previously observed [12]. When PpSec16-
YFP was simultaneously expressed in S. cerevisiae, this protein
colocalized with CFP-tagged S. cerevisiae Sec13 (ScSec13-CFP) at
tER sites, and now PpSec12-GG was also concentrated at tER
sites (Fig. 2B). By contrast, expression of PpSec16-YFP in S.
cerevisiae did not change the localization of ScSec12-GG (Fig. 2B),
indicating that the recruitment of PpSec12-GG to tER sites was
due to a specific interaction with PpSec16-YFP.
A C-terminal region of PpSec16 is required for PpSec12
localization
As shown in Fig. 3A, PpSec16 contains a central conserved
domain (CCD) as well as a conserved C-terminal region (CTR)
that is essential for life [8,14]. To determine which parts of
PpSec16 affect PpSec12 localization, we systematically deleted
nonessential regions of PpSec16 by chromosomal gene replace-
ment, and then examined PpSec12 localization in these cells. All of
these strains showed normal tER localization of PpSec12-GG
(Fig. 3A,B).
S. cerevisiae and its close relatives contain not only Sec12, but also
the Sec12-like protein Sed4, which interacts with a C-terminal
fragment of S. cerevisiae Sec16 (ScSec16) [24,25,26]. Therefore, we
suspected that PpSec12 might interact with a C-terminal fragment
of PpSec16. To test this hypothesis, we repeated the experiment of
simultaneously overexpressing PpSec12 and PpSec16 in P. pastoris,
except that the overexpressed PpSec16 was truncated. This
truncation removed residues 1967–2550, which encompassed the
CTR plus a nonconserved stretch between the glutamine-rich
region and the CTR. The truncated PpSec16 was found at tER
sites, but unlike intact PpSec16 (see Fig. 1), the truncated PpSec16
was unable to restore tER localization to overexpressed PpSec12
(Fig. 4A). We also expressed the truncated version of PpSec16 in S.
cerevisiae cells that simultaneously expressed PpSec12. Unlike intact
PpSec16 (see Fig. 2B), the truncated PpSec16 was unable to recruit
PpSec12 to tER sites (Fig. 4B). These results indicate that a C-
terminal fragment of PpSec16 is needed for the tER localization of
PpSec12.
To determine which parts of the C-terminal fragment of
PpSec16 interact with PpSec12, we made deletions within the C-
terminal fragment, and then simultaneously overexpressed
PpSec12 and a mutant PpSec16 in P. pastoris. Two hundred cells
Figure 1. Recruitment of overexpressed PpSec12 to tER sites in P. pastoris by simultaneous overexpression of PpSec16. PpSec12 was
tagged with the Glu-Glu epitope (PpSec12-GG) by gene replacement, and a second untagged copy of PpSec12 was expressed in the same cells using
the methanol-inducible AOX1 promoter, resulting in a high total level of PpSec12 expression. Top row: in a strain overexpressing PpSec12, PpSec16
was expressed at normal levels after being tagged by gene replacement with GFP. A small fraction of the PpSec12-GG colocalized with PpSec16-GFP,
but most of the PpSec12-GG was in the general ER as indicated by the prominent nuclear envelope signal. Bottom row: in a strain overexpressing
PpSec12, PpSec16-GFP was overexpressed as a second copy using the AOX1 promoter. Most of the PpSec12-GG colocalized with PpSec16-GFP in
exaggerated tER sites. Scale bar, 2 mm.
doi:10.1371/journal.pone.0031156.g001
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colocalized with PpSec16 at tER sites, or partially colocalized, or
not colocalized (Fig. 5). In the control strain overexpressing full-
length PpSec16, ,90% of the cells showed strong colocalization of
PpSec12 with PpSec16. Deletion of the entire C-terminal
fragment of PpSec16 resulted in ,1% of the cells showing strong
colocalization. Deletion of the nonconserved stretch (residues
1967–2340) had a mild effect, with ,80% of the cells showing
strong colocalization, indicating that the nonconserved stretch
within the C-terminal fragment plays some role in recruiting
PpSec12 to tER sites. Deletion of the CTR (residues 2340–2550)
had a dramatic effect, with only ,5% of the cells showing strong
colocalization, indicating that the CTR plays a major role in
recruiting PpSec12 to tER sites. Smaller deletions that truncated
the CTR had intermediate effects. These results indicate that
recruitment of PpSec12 to tER sites requires a C-terminal
fragment of PpSec16, and that the bulk of this interaction is
mediated by the CTR.
A C-terminal fragment of PpSec16 binds the cytosolic
domain of PpSec12 in vitro
To determine if a C-terminal fragment of PpSec16 interacts
directly with the cytosolic domain of PpSec12, we used bacterial
expression to produce glutathione S-transferase (GST) fused to
residues 1960–2550 of PpSec16. In parallel, we used bacterial
expression to produce the cytosolic domain of PpSec12 with a C-
terminal hexahistidine tag. Glutathione-agarose beads were
incubated with a lysate from cells expressing either GST alone
or GST-Sec16(1960–2550), and were subsequently incubated with
a lysate from cells expressing PpSec12(cyto)-His6 (Fig. 6, ‘‘I’’). The
unbound material was collected (Fig. 6, ‘‘U’’), and the bound
protein (Fig. 6, ‘‘B’’) was eluted from the beads with glutathione.
With GST alone, all of the PpSec12(cyto)-His6 was in the
unbound fraction. With GST-PpSec16(1960–2550), none of the
PpSec12(cyto)-His6 was in the unbound fraction and a significant
amount could be eluted from the beads with glutathione. The
remaining PpSec12(cyto)-His6 that had bound to GST-
PpSec16(1960–2550) was apparently lost during the wash steps
(data not shown), suggesting that this binding is readily reversible.
These data provide evidence for a direct interaction between a C-
terminal fragment of PpSec16 and the cytosolic domain of
PpSec12.
Viability of S. cerevisiae does not require strong
interaction of a Sec12 family member with Sec16
PpSec12 binds to the CTR of PpSec16, and Sed4 binds to the
CTR of ScSec16, and the CTR is essential for life, so we
wondered whether the interaction of a Sec12 family member with
Sec16 is essential. To answer this question, we took advantage of
the finding that PpSec12 can replace ScSec12 in S. cerevisiae [12]
Figure 2. Recruitment of PpSec12 to tER sites in S. cerevisiae by simultaneous expression of PpSec16. (A) S. cerevisiae cells expressed S.
cerevisiae Sec13-CFP (ScSec13-CFP) plus either PpSec12-GG (top row) or ScSec12-GG (bottom row). Both versions of Sec12 localized to the general ER.
(B) Same as (A), except that the S. cerevisiae cells also expressed PpSec16-YFP under control of the inducible GAL10 promoter. PpSec16-YFP
colocalized with ScSec13-CFP at tER sites, and now tER localization was observed for PpSec12-GG but not for ScSec12-GG. Scale bar, 2 mm.
doi:10.1371/journal.pone.0031156.g002
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of PpSec16. Shading indicates conserved regions while hatch marks indicate an essential region. CCD, central conserved domain; Q, glutamine-rich
region; CTR, C-terminal conserved region. Deletions introduced by gene replacement are indicated. None of these deletions affected PpSec12
localization. (B) Representative images of PpSec12-GG localization in P. pastoris cells carrying the indicated deletions in PpSec16. Scale bar, 2 mm.
doi:10.1371/journal.pone.0031156.g003
Figure 4. Requirement of the C-terminal portion of PpSec16 for tER localization of PpSec12 in both P. pastoris and S. cerevisiae. (A) As
in Fig. 1, P. pastoris cells expressed PpSec12-GG from the endogenous promoter plus untagged Sec12 from the AOX1 promoter, resulting in a high
total level of PpSec12 expression. In the same cells, a truncated version of PpSec16 lacking residues 1967–2550 was tagged with GFP and
overexpressed as a second copy using the AOX1 promoter. PpSec16(D1967–2550)-GFP was found in punctate tER sites. By contrast to the result
obtained when full-length PpSec16 was expressed (Fig. 1), PpSec12-GG was found in the general ER. (B) S. cerevisiae cells expressed the same
truncated version of PpSec16 as in (A), except that the protein was tagged with YFP and was expressed under control of the GAL10 promoter. As in
Fig. 2B, ScSec13-CFP and PpSec12-GG were also expressed in these cells. By contrast to the result obtained when full-length PpSec16 was expressed
(Fig. 2B), PpSec12-GG was found in the general ER. Scale bars, 2 mm.
doi:10.1371/journal.pone.0031156.g004
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above). The earlier Sec12 replacement was performed with a SED4
strain of S. cerevisiae, but if PpSec12 replaced ScSec12 in a sed4D
strain, there would be no strong interaction of a Sec12 family
member with ScSec16. Therefore, the crucial question is whether
PpSec12 can still replace ScSec12 in a sed4D strain of S. cerevisiae.
This experiment was performed using a plasmid shuffle
approach. The chromosomal SED4 and SEC12 genes were
deleted, and were replaced using two plasmids: a URA3 plasmid
carrying SED4, and a LEU2 plasmid carrying either ScSEC12 or
PpSEC12. 5-fluoroorotic acid (5-FOA) was then used to select for
cells that had lost the URA3 SED4 plasmid. The cells that had lost
the URA3 SED4 plasmid were viable regardless of whether the
LEU2 plasmid carried ScSEC12 or PpSEC12 (Fig. 7). Thus,
PpSec12 can replace ScSec12 even in a sed4D strain of S. cerevisiae,
indicating that a strong interaction of a Sec12 family member with
Sec16 is not essential for life in this yeast.
Human Sec12 localizes to tER sites and binds a C-
terminal fragment of Sec16A
Concentration of Sec12 at tER sites has only been described
in P. pastoris, so an obvious question is whether the Sec12–Sec16
Figure 5. Requirement of the C-terminal portion of PpSec16 for recruiting overexpressed PpSec12 to tER sites. As in Fig. 1, PpSec16-
GFP was overexpressed in P. pastoris cells overexpressing PpSec12, except that deletions were introduced as indicated near the C-terminus of
PpSec16. Two hundred randomly chosen cells from each of the indicated P. pastoris strains were examined by immunofluorescence and scored for
colocalization of PpSec12-GG with PpSec16-GFP. Cells in which nearly all of the PpSec12-GG overlapped with PpSec16-GFP were scored as having
strong colocalization (+). Cells in which PpSec12-GG showed clear concentration in the PpSec16-GFP puncta but also showed prominent staining
outside of these puncta were scored as having partial colocalization (+/2). Cells showing no visible concentration of PpSec12-GG in the PpSec16-GFP
puncta were scored as having no colocalization (2). Colocalization was virtually abolished by deleting the entire C-terminal portion of PpSec16, and
was strongly reduced by deleting only the C-terminal conserved region (CTR).
doi:10.1371/journal.pone.0031156.g005
Figure 6. Biochemical interaction of the C-terminal portion of
PpSec16 with the cytosolic domain of PpSec12. Glutathione-
agarose beads were incubated with a bacterial lysate from cells
expressing either GST alone, or GST fused to the C-terminal residues
1960–2550 of PpSec16. Sufficient lysate was used to saturate the
binding sites on the glutathione-agarose. A second incubation was then
performed with sub-saturating amounts of a bacterial lysate from cells
expressing a hexahistidine-tagged version of the cytosolic domain of
PpSec12 (PpSec12(cyto)-His6). The beads were centrifuged, and the
unbound material in the supernatant was collected. Bound protein was
eluted from the beads with 100 mM glutathione. I, input (100% relative
to other lanes); U, unbound; B, bound. PpSec12(cyto)-His6 bound to the
beads carrying GST-PpSec16(1960–2550) but not to the beads carrying
GST alone.
doi:10.1371/journal.pone.0031156.g006
Figure 7. Viability of S. cerevisiae cells carrying PpSEC12 as the
only gene from the SEC12 family. A plasmid shuffle was performed
in sed4D sec12D cells, with SED4 in a URA3 plasmid plus either ScSEC12
(top row) or PpSEC12 (middle row) in a LEU2 plasmid. Both strains grew
on rich media (YPD) and also on media containing 5-FOA, indicating
that PpSEC12 could replace ScSEC12 even in the absence of SED4.A sa
control, sec12D cells carrying ScSEC12 on a URA3 plasmid were plated
on the same media, and no growth was seen in the presence of 5-FOA.
doi:10.1371/journal.pone.0031156.g007
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this issue, we revisited the localization of human Sec12. It was
previously reported that human Sec12 was found throughout
the ER [27], but the immunofluorescence data were ambiguous.
We therefore repeated this experiment using an improved
immunofluorescence protocol [28]. The labeling of human
Sec12 was consistent with localization to the ER network, but
punctate Sec12 labeling was also se e ni nt E Rs i t e s( F i g .8 A )t h a t
Figure 8. Colocalization of mammalian Sec12 with Sec16A at tER sites. (A) U2OS human osteosarcoma cells were subjected to
immunofluorescence as described [28] using commercial antibodies against human Sec12 and Sec16A. Scale bar, 2 mm. (B) Plasmids encoding YFP-
tagged full-length human Sec12 and CFP-tagged full-length Sec16B were co-transfected into U2OS cells. The cells were imaged at 16 h post-
transfection, a time point that yielded relatively low expression levels. Scale bar, 2 mm. (C) HeLa cells were transfected where indicated with plasmids
encoding either monomeric GFP fused to a C-terminal region (‘‘CTR’’) of human Sec16A (residues 1909–2332), or an N-terminally triple-FLAG-tagged
cytosolic domain (‘‘Cyt’’) of human Sec12 (residues 1–386). At 24 h post-transfection, the cells were lysed and the lysate was subjected to
immunoprecipitation (‘‘IP’’) with anti-FLAG antibody. The immunoprecipitated material and 5% of the lysate (‘‘5% Input’’) was subjected to SDS-PAGE
followed by immunoblotting with either anti-FLAG or anti-GFP antibody.
doi:10.1371/journal.pone.0031156.g008
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yeast Sec16.
This result was confirmed by expressing GFP-tagged human
Sec12. At various expression levels, GFP-Sec12 signal was present
in the general ER but punctate structures were also visible (Fig.
S2). As the expression level increased, the punctate structures
became progressively larger (Fig. S2). This effect is reminiscent of
the exaggerated tER sites seen with simultaneous overexpression
of PpSec12 and PpSec16 in P. pastoris (see Figs. 1 and S1), except
that in mammalian cells, overexpression of Sec12 alone suffices to
generate enlarged structures. To verify that the punctate structures
were tER sites, YFP-tagged Sec12 was co-expressed with CFP-
tagged Sec16B, which is a tER-localized Sec16 homolog [17]. A
large fraction of the YFP-Sec12 puncta overlapped with the CFP-
Sec16B puncta at both low and high expression levels (Fig. 8B, and
data not shown). We conclude that Sec12 is concentrated at tER
sites in mammalian cells.
Sec16A contains a C-terminal region that appears to be related
to the CTR of yeast Sec16 [17], suggesting that this domain of
Sec16A may be responsible for recruiting human Sec12 to tER
sites. As an initial test of this idea, we expressed in HeLa cells a
FLAG-tagged cytosolic domain of human Sec12 together with a
GFP-tagged C-terminal region of Sec16A. When the FLAG-
tagged Sec12 fragment was immunoprecipitated, we reproducibly
observed co-immunoprecipitation of a small amount of the GFP-
tagged Sec16A fragment (Figure 8C). This result is consistent with
a possible role of the C-terminal region of Sec16A in recruiting
human Sec12 to tER sites.
Discussion
The cytosolic domain of PpSec12 interacts with a tER-localized
partner protein, and this interaction is readily reversible [12]. A
likely candidate for the partner protein was Sec16, which binds to
the cytosolic surface of the ER membrane at tER sites [8,14].
Indeed, we have now obtained two lines of evidence that PpSec16
recruits PpSec12 to tER sites. The first line of evidence comes
from overexpression studies in P. pastoris. When PpSec12 is
overexpressed, most of the molecules are delocalized to the general
ER because the tER-localized partner protein has been saturated
[12]. We showed that simultaneous overexpression of PpSec16
suppresses the delocalization of overexpressed PpSec12, as would
be expected if PpSec16 is the saturable partner protein. The
second line of evidence comes from heterologous expression
studies in S. cerevisiae. When PpSec12 is expressed in S. cerevisiae,i ti s
found in the general ER, presumably because the interaction with
ScSec16 is too weak to confer tER localization. We showed that
simultaneous expression of PpSec16 in S. cerevisiae results in
recruitment of PpSec12 to tER sites, consistent once again with the
idea that PpSec16 is the partner protein for PpSec12.
In S. cerevisiae, the Sec12-like protein Sed4 binds to a C-terminal
fragment of ScSec16 [24]. Similarly, we showed that PpSec12
binds to a C-terminal fragment of PpSec16. When this C-terminal
fragment of PpSec16 is deleted, the truncated PpSec16 fails to
recruit PpSec12 to tER sites either in P. pastoris or in S. cerevisiae.
Biochemical pull-down experiments with recombinant proteins
confirmed that a C-terminal fragment of PpSec16 can interact
directly with the cytosolic domain of PpSec12. We found that the
conserved C-terminal region (CTR) of PpSec16 is the major site of
interaction with PpSec12, although a nonconserved stretch
upstream of the CTR contributes to this interaction.
Deletion of the CTR is lethal [14], so an important question is
whether the Sec12–Sec16 interaction is essential for life. Although
we cannot yet answer this question with certainty, the data suggest
that the Sec12–Sec16 interaction is nonessential. We found that
PpSec12 binds weakly or not at all to ScSec16, and yet PpSec12
can replace ScSec12 in S. cerevisiae, even when SED4 has been
deleted to ensure that PpSec12 is the only Sec12 family member in
the cells. Thus, the CTR probably has an essential function apart
from binding Sec12. The CTR interacts with Sec23 in both yeast
and mammalian cells [14,17], so this Sec23 interaction may be the
essential function of the CTR, with the Sec12 interaction playing a
secondary role. This idea could be tested by identifying point
mutations that selectively disrupt either the Sec12-CTR interac-
tion or the Sec23-CTR interaction.
How conserved is the Sec12–Sec16 interaction? We showed
here that Sec12 is concentrated at tER sites in human cells, and
that the cytosolic domain of human Sec12 is capable of associating
with the C-terminal region of human Sec16A. Recently, a Sec12–
Sec16 interaction was also detected in Caenorhabditis elegans [29].
The combined data suggest that Sec12 has a conserved interaction
with Sec16. This interaction may play a previously unsuspected
role in tER organization, because exaggerated tER sites are seen
upon simultaneous overexpression of PpSec12 and PpSec16 in P.
pastoris or upon overexpression of human Sec12 in cultured
mammalian cells.
Does the Sec12–Sec16 interaction modulate Sec12 function, or
Sec16 function, or both? One possibility is that this interaction
boosts the efficiency of COPII vesicle formation by concentrating
Sec12 at tER sites, thereby enhancing local activation of Sar1 [30].
On the other hand, S. cerevisiae Sed4 binds Sec16 but lacks
detectable guanine nucleotide exchange activity for Sar1 [24,31],
suggesting that the Sed4–Sec16 interaction serves to modulate
Sec16 function. In support of this idea, overexpression of Sed4
suppresses temperature-sensitive sec16 mutations [24]. We infer
that Sed4 and Sec12 may share the ability to influence Sec16
function.
It is noteworthy that the CTR of Sec16 interacts both with
Sec12, which is the guanine nucleotide exchange factor for Sar1,
and with Sec23, which is the GTPase activating protein for Sar1.
An intriguing question is whether the Sec12–Sec16 and Sec23–
Sec16 interactions are mutually exclusive and perhaps antagonis-
tic. Further biochemical and structural studies are needed to
understand the complex interplay between Sec16 and the COPII
pathway.
Materials and Methods
Fluorescence microscopy
Immunofluorescence microscopy was carried out as previously
described [11,12] except that the fixed cells were incubated in
lyticase for 30 min at 30uC. For the yeast studies, samples were
viewed with a Zeiss Axioplan 2 epifluorescence microscope using a
1.4-NA 100X Plan Apo objective, and images were captured with
a Hamamatsu digital camera followed by processing in Adobe
Photoshop to adjust brightness and contrast. For the mammalian
cell studies, samples were viewed with a Zeiss LSM 510 META
confocal microscope.
Expression in P. pastoris
All P. pastoris strains were derivatives of PPY12 [32]. P. pastoris
cells were transformed with linearized integrating vectors using
electroporation [33]. The constructs used in this study are
documented with annotated sequence files in Sequence Archive
S1. Overexpression in P. pastoris was achieved using the strong
methanol-inducible AOX1 promoter as previously described [12].
Briefly, cells were grown overnight at 30uC in 5 mL of glycerol-
containing SYG medium. This medium was then removed by
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medium and then resuspended in SYM. After 8 h of growth with
shaking in SYM, cells were either fixed and processed for
immunofluorescence, or visualized directly by fluorescence
microscopy. We showed previously that under these conditions,
PpSec12 is overexpressed ,190-fold [12].
Tagging of endogenous PpSec12 was achieved as follows. A
BamHI fragment containing a modified 39 portion of PpSEC12
[12] was inserted into the BamHI site of pUC19-HIS4 [33] to
create pLY051. This plasmid was then linearized with StyI and
integrated at the SEC12 locus via homologous recombination to
tag PpSec12 with a Glu-Glu epitope tag, yielding strain EM19.
Regulated expression of PpSec12 was achieved as follows. pEM04
was created from pIB4 [33] by replacing most of P. pastoris HIS4
with P. pastoris ARG4. A gene encoding PpSec12-GG [12] was
subcloned between the EcoRI and PstI sites of pEM04 to create
pEM13. This plasmid was linearized by partial digestion with
PflMI and then integrated at the SEC12 locus to yield strain
EM15, which has two tandem copies of PpSEC12: one copy that
encodes PpSec12-GG under control of the endogenous promoter,
and a second copy that encodes untagged PpSec12 under control
of the AOX1 promoter.
To label endogenous PpSec16 with monomeric enhanced GFP
(mEGFP) [34], a PCR fragment spanning from codon 1178 of
PpSEC16 to ,400 bp downstream of the stop codon was PCR
amplified and inserted into the SmaI site of pUC19-HIS4 to create
pME004. Then a fragment of PpSEC16 fused to mEGFP was
excised from pUC19-ARG4-S16C-mEGFP [8] using BspEI and
XmnI, and inserted between the BspEI and SfoI sites of pME004
to create pME008. This plasmid was linearized with PshAI and
integrated at the SEC16 locus of strain EM15, yielding strain
EM34.
Because full-length PpSEC16 is toxic to E. coli, the PpSEC16-GFP
overexpression construct was assembled by in vitro ligation as
previously described [8] using plasmids pEM08, which contains
the AOX1 promoter followed by codons 1022–2550 of PpSEC16
followed by mEGFP, and pEM12, which contains the AOX1
promoter followed by codons 1–1678 of PpSEC16. A ligation
product of fragments derived from pEM08 and pEM12 was
integrated at the HIS4 locus of strain EM15, yielding strain EM17.
Two methods were used to create pEM08-type plasmids encoding
deletions in a C-terminal fragment of PpSec16. In the first
method, portions near the 39 end of PpSEC16 were deleted in
pEM08 by primer-directed mutagenesis to create pEM48 (lacking
codons 1967–2340), pEM49 (lacking codons 2341–2550), pEM50
(lacking codons 2501–2550), and pEM55 (lacking codons 2451–
2550). In the second method, a pIB4 derivative was created in
which codons 1505–1967 of PpSEC16 were followed by mEGFP to
create pEM43. pEM43, pEM48, pEM49, pEM50, and pEM55
were each used in an in vitro ligation reaction with pEM12, and the
products were integrated at the HIS4 locus of strain EM15,
yielding strains EM16, EM25, EM26, EM27, and EM38,
respectively.
Deletion of nonessential PpSEC16 regions was accomplished by
integrating linearized deletion constructs at the PpSEC16 locus of
strain EM19. This approach employed derivatives of plasmids
pME005 and pLY100, as follows. pME005 was created by
inserting codons 1178–2550 of PpSEC16 plus ,400 bp of
downstream sequence into the SmaI site of pUC19-ARG4 [11].
Primer-directed mutagenesis of pME005 deleted codons 1967–
2340 to create pEM54, which was linearized with PshAI for
integration. Alternatively, a BstEII fragment spanning codons
682–1633 of PpSEC16 was inserted into the BstEII site of
pME005, and then primer-directed mutagenesis deleted codons
1010–1960 to create pLY080, which was linearized by partial
digestion with XbaI for integration. pLY100 was created by
inserting codons 1–1461 of PpSEC16 plus ,500 bp of upstream
sequence into pUC19-ARG4. Primer-directed mutagenesis of
pLY100 deleted either codons 500–648 to create pLY114, or
codons 648–1010 to create pLY115, or codons 1–500 to create
pLY116. These three plasmids were linearized with BssHII for
gene replacement at the PpSEC16 locus.
A strain expressing Sec13-DsRed as well as overexpressing
PpSec12-GG and PpSec16-GFP was made as follows. The KanMX
gene [35] was PCR amplified and inserted into the SspI site of
pUC19 to create pUC19-KanMX. An EcoRI-XmnI fragment
encoding a C-terminal portion of Sec13 fused to DsRed-Monomer
was subcloned from pUC19-ARG4-Sec13-DsRed.M1 [8] into
pUC19-KanMX to create pEM42. This plasmid was then
linearized using MscI and integrated into the SEC13 locus of
strain EM17, yielding strain EM30.
Expression in S. cerevisiae
All S. cerevisiae strains were derivatives of JK9-3d [36]. The
constructs used in this study are documented with annotated
sequence files in Sequence Archive S1. Overexpression in S.
cerevisiae was achieved using the strong galactose-indicuble GAL10
promoter [37]. Induction was carried out as follows. Cells were
grown overnight in synthetic media containing dextrose. When the
culture reached an OD600 of ,0.4, the cells were transferred to
synthetic media containing galactose, grown for 4.5 h, and then
fixed and processed for immunofluorescence.
Heterologous expression of P. pastoris genes in S. cerevisiae was
performed as follows. The starting strain carried a deletion of the
endogenous SEC12 gene, with the cells being kept alive by a 2m
URA3 plasmid [38] encoding a Glu-Glu-tagged Sec12 protein
under control of the ScSEC12 promoter. This plasmid was either
YEplac195-ScSec12-GG, which encodes ScSEC12-GG, or YE-
plac195-PpSec12-GG, which encodes PpSEC12-GG [12]. The
chromosomal ScSEC13 gene in these strains was then tagged with
a triple-CFP cassette using pUC19-URA3-SEC13-CFPx3 that had
been linearized with BstEII, yielding strains LY05 and LY06.
Additional regulated expression of PpSec16-YFP was achieved
using the GAL10 promoter. Because the full-length PpSEC16 gene
is toxic to E. coli, the PpSec16-YFP plasmid was constructed by in
vitro ligation of fragments from pEM45, which encodes a 59
portion of PpSEC16, and pEM46, which encodes a 39 portion of
PpSEC16 fused to a triple-YFP cassette. Strains LY03 and LY04
expressed ScSec13-3xCFP, PpSec16-3xYFP, and either ScSec12-
GG or PpSec12-GG, respectively.
GST pull-down and immunoblotting
To express GST fused to a C-terminal fragment of PpSec16,
codons 1960–2550 of PpSEC16 were subcloned between the XmaI
and XhoI sites of pGEX-4T-1 (GE Healthcare) to create pME107.
To express the cytosolic domain of PpSec12 fused to a
hexahistidine tag, codons 1–337 of PpSEC12 were amplified by
PCR and inserted between the NdeI and XhoI sites of pET21a(+)
(Novagen), yielding pET21a(+)-PpSec12(cyto). pME107 and
pET21a(+)-PpSec12(cyto) were each transformed into E. coli
Rosetta cells (Novagen) containing the pLysS plasmid. For protein
expression, a 50-mL culture of cells was grown at 37uC with
shaking for 5 h, and then protein expression was induced with
1 mM isopropyl-b-D-thiogalactopyranoside for a further 4 h.
Cell lysis and GST pull-down were conducted using the
Thermo Scientific Pierce ProFound Pull-Down GST Protein:Pro-
tein Interaction kit. A brief protocol follows. All incubations and
washes were performed using a 1:1 mixture of ProFound Lysis
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30 minutes in the presence of Benzonase (Novagen), and lysates
were clarified by centrifugation at 100,0006g to obtain the Input
fraction. Glutathione-agarose beads were incubated for 1 h at 4uC
with clarified lysate from cells expressing GST-Sec16(1960–2550).
The beads were washed, and then incubated for 1 h at 4uC with
clarified lysate from cells expressing PpSec12(cyto)-His6. At this
point the beads were spun in a column and the flow-through was
collected as the Unbound fraction. The beads were then washed,
followed by a 10-minute incubation at room temperature with
100 mM glutathione to elute the Bound fraction.
Equivalent amounts of the Input, Bound, and Unbound
fractions were boiled in SDS-PAGE sample buffer and loaded
onto an SDS-PAGE gel. Separated proteins were transferred to
PVDF membranes, and the hexahistidine-tagged PpSec12 cyto-
solic domain was detected using a 6-His monoclonal antibody
(Covance, catalog no. MMS-156P) and the Supersignal West
Femto kit (Pierce).
Plasmid shuffle experiment
pEM60 was made by ligating a PCR product containing SED4,
including the promoter and terminator, into the CEN URA3
plasmid YCplac33 [38]. pEM61 and pEM62 were created by
subcloning ScSEC12-GG or PpSEC12-GG, respectively, together
with the ScSEC12 promoter [12] into the 2 mm LEU2 plasmid
YEplac181 [38].
Strains EM59 to EM62 were created by first deleting one copy
of the SED4 coding sequence in a diploid strain in which one copy
of ScSEC12 had been replaced by KanMX [12]. To delete SED4,
the cells were transformed with a PCR product containing a
hygromycin B resistance gene [39] flanked by sequences upstream
and downstream of the SED4 coding sequence, with selection on
rich medium containing 200 mg/mL hygromycin B (US Biolog-
icals). Next, pEM60 plus either pEM61 or pEM62 were
introduced to create strains EM54 and EM55, respectively. These
strains were then sporulated and subjected to tetrad dissection. A
sporulation defect was observed, with two- and three-spore tetrads
outnumbering four-spore tetrads, probably reflecting a role for
SED4 during sporulation [40]. Haploid clones were tested on
selective media to assess the presence of plasmids and drug
resistance markers.
Survival in the absence of SED4 was tested as follows. Strains
EM59 to EM62, plus a control strain in which a ScSEC12 deletion
was rescued by YEplac195-ScSEC12-GG, were grown to mid-log
phase in rich medium overnight to give the cells an opportunity to
lose the URA3 plasmids. Equal numbers of cells were then spotted
onto plates containing 1 g/L 5-FOA (US Biologicals). Plates were
incubated in the dark at 30uC for several days to allow for growth
of colonies lacking the URA3 plasmids.
Analysis of mammalian Sec12 and Sec16
For immunofluorescence, human Sec12 was detected using an
affinity purified goat anti-human PREB antibody from R&D
Systems (cat. #AF5557, diluted 1:50), and Sec16A was detected
using a rabbit polyclonal anti-KIAA0310 antibody from Bethyl
Laboratories (cat. #BL2467, diluted 1:50). These primary
antibodies were detected with Alexa Fluor 594 donkey anti-goat
and Alexa Fluor 488 chicken anti-rabbit IgG secondary antibodies
(Invitrogen), respectively. For immunoblotting, GFP was detected
using a rabbit polyclonal antibody (Abcam cat. #ab290, diluted
1:1000), and the FLAG epitope was detected using a mouse
monoclonal antibody (Sigma cat. #F1804, diluted 1:2000).
For expression of fluorescently tagged proteins in U2OS cells,
full-length human Sec12 was N-terminally tagged with monomeric
enhanced GFP (mEGFP) or YFP (mEYFP), and full-length Sec16B
was N-terminally tagged with monomeric enhanced CFP
(mECFP) [34]. The human Sec12 and Sec16B genes were
amplified from cDNAs by PCR and subcloned into pEGFP-C1
(Clontech) downstream of the EGFP gene, followed by replace-
ment of EGFP with either mEGFP or mEYFP or mECFP. Sec16B
is identical to the gene that we previously designated Sec16S [17].
These constructs are documented with annotated sequence files in
Sequence Archive S1.
For co-immunoprecipitation, tagged fragments of human
Sec12 and Sec16A [17] were expressed transiently from the
CMV promoter. The cytosolic domain of human Sec12 (codons
1–386) was amplified from a cDNA by PCR and subcloned into
pCMV-3FLAG-1A (Stratagene) downstream of a triple-FLAG
cassette. A C-terminal region of Sec16A (codons 1909–2332) was
amplified from a cDNA by PCR and subcloned into pmEGFP-
C1, which is a derivative of pEGFP-C1 (Clontech) carrying the
monomerizing A206K mutation [34]. In the case of Sec16A,
which we previously designated Sec16L [17], our original
description of the gene overlooked the first 178 codons [18], so
we added those codons for the numbering used here. Because our
cDNA lacks the 75-bp intron between the 28th and 29th exons
[17], our numbering for the C-terminal fragment of Sec16A
differs by 25 amino acids from the numbering used elsewhere
[18]. These constructs are documented with annotated sequence
files in Sequence Archive S1. Plasmids were transfected into
HeLa cells using calcium phosphate transfection. The cells were
harvested at 24 h post-transfection, and lysed in 50 mM Tris-
HCl, pH 7.9, 50 mM NaCl, 1 mM phenylmethylsulfonyl fluo-
ride, 0.5% NP-40 supplemented with the Complete mini protease
inhibitor cocktail (Roche). Approximately 3 mg of cell lysate was
used for each immunoprecipitation. Protein A-agarose beads
(Calbiochem) were pre-blocked with 1% bovine serum albumin
and then incubated at 4uC with polyclonal rabbit anti-FLAG
antibody (Sigma). Immunoprecipitation was performed overnight
at 4uC. Then the beads were washed three times with 20 mM
Na
+-HEPES, pH 7.9, 100 mM NaCl, 0.1% NP-40. Finally,
bound material was eluted by boiling in SDS-PAGE sample
buffer, followed by SDS-PAGE, transfer to nitrocellulose, and
immunoblotting [17].
Supporting Information
Figure S1 Colocalization of PpSec16 with PpSec13 in P.
pastoris cells overexpressing both PpSec12 and PpSec16.
The method of Fig. 1 was used to achieve simultaneous
overexpression of PpSec12 and GFP-tagged PpSec16. In addition,
PpSec13 was tagged with DsRed by gene replacement. The
overexpressed PpSec16-GFP colocalized with PpSec13-DsRed,
confirming that the structures labeled with PpSec16-GFP were
exaggerated tER sites. Scale bar, 2 mm.
(TIF)
Figure S2 Localization of GFP-tagged human Sec12 at
different expression levels. A plasmid encoding GFP-tagged
full-length human Sec12 was transfected into U2OS human
osteosarcoma cells. The cells were imaged at either (A) 12 h, (B)
24 h, or (C, D) 36 h post-transfection. Representative images are
shown for cells expressing GFP-Sec12 at (A) low, (B) moderate, (C)
high, and (D) very high levels. These cells were imaged at different
exposure levels according to their fluorescence intensities. As the
expression level of GFP-Sec12 increased, the punctate structures
became progressively larger. Scale bar, 5 mm.
(TIF)
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